| 查看: 174 | 回复: 0 | |||
| 当前主题已经存档。 | |||
ronghui05铜虫 (小有名气)
|
[交流]
医学类，谢谢！
|
||
| Adenovirus-mediated gene therapy shows promise for cancer therapy, but transgene expression of replication-defective adenovirus may be low and transient in clinical settings. Recent reports have shown that the use of a conditionally replication-competent adenovirus (CRAd) enhanced the gene transduction of a replication-defective adenovirus vector. The control of tumor-stromal interactions has also been determined to be important in cancer therapy. In this study, we investigated the effect of the human telomerase reverse transcriptase (hTERT)-CRAd, Ad5/3hTERTE1, which possesses the tumor-specific hTERT promoter with the chimeric fiber 5/3, on the transgene expression and therapeutic efficacy of a replication-defective adenovirus vector expressing NK4 under the control of the CMV promoter, Ad-NK4. In addition, we established a new strategy to target both cancer cells and cancer-stromal interactions. Human pancreatic cancer cells were infected with Ad-NK4 and either Ad5/3hTERTE1 (CRAd-combination group) or Ad5/3hTERTLuc (control-combination group). In the CRAd-combination group, Ad-NK4-delivered transgene expression was increased, leading to an enhanced inhibitory effect on the invasion of cancer cells. In in vivo experiments, NK4 expression within tumors and its inhibitory effect on tumor growth, angiogenesis, and metastasis were enhanced in the CRAd-combination group. These results suggest that hTERT-CRAd enhances the transgene expression and therapeutic efficacies of Ad-NK4, possibly through the in-trans replication of Ad-NK4 induced by adenovirus E1 derived from co-infected hTERT-CRAd. This approach may be a promising combination therapy against advanced pancreatic cancer. |
回复此楼» 猜你喜欢
窗边初夏的小雨
已经有5人回复
-
2026年申博-电池方向
已经有11人回复
-
26年申博自荐-计算机视觉
已经有4人回复
-
导师各种操作恶心咋办
已经有8人回复
-
2026博士申请求助
已经有5人回复
-
研究生做的很差，你们会让毕业吗？
已经有11人回复
-
求碳排放博导；方向是LCA、生命周期可持续发展以及碳排放
已经有7人回复
-
2026博士或科研助理转27年博士
已经有7人回复
-
国自科送审了吗
已经有11人回复
-
博士招生
已经有5人回复